Literature DB >> 28427047

Co-Activation of TGFβ and Wnt Signalling Pathways Abrogates EMT in Ovarian Cancer Cells.

Tulika Mitra1, Sib Sankar Roy1,2.   

Abstract

BACKGROUND/AIMS: The aggressive property of ovarian cancer (OC) in terms of epithelial-mesenchymal transition (EMT), proliferation and metastasis are of major concern. Different growth factors including TGFβ are associated with regulating these molecular events but the underlying mechanisms remain unclear. The aim of this report is to decipher the regulation of EMT by co-activation of TGFβ and Wnt signalling cascades in gaining malignancy.
METHODS: The expression of the different components of signalling events were analyzed by QPCR, Western blot, Immunofluorescence microscopy and flow cytometry. β-catenin promoter activity was checked by luciferase assay.
RESULTS: We observed reduced EMT in ovarian cancer cells upon co-activation with TGFβ1 and LiCl as shown by the expressions of epithelial/mesenchymal markers and the EMT promoting factor, Snail1, accompanied by decrease in the invasion and migration of the cells compared to individual pathway activation. A detailed study of the mechanism suggested reduction in the β-catenin and p-GSK3b (Ser 9) levels to be the driving cause of this phenomenon, which was reversed upon co-activation with higher concentrations of LiCl.
CONCLUSIONS: Therefore, tumourigenesis might be affected by the concentration of ligand/ growth factors for the respective signalling pathways activated in the tumour microenvironment and interaction between them might alter tumourigenesis.
© 2017 The Author(s)Published by S. Karger AG, Basel.

Entities:  

Keywords:  EMT; TGFβ; Wnt; β-catenin

Mesh:

Substances:

Year:  2017        PMID: 28427047     DOI: 10.1159/000464436

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Translocating proteins compartment-specifically alter the fate of epithelial-mesenchymal transition in a compartmentalized Boolean network model.

Authors:  Péter Mendik; Márk Kerestély; Sebestyén Kamp; Dávid Deritei; Nina Kunšič; Zsolt Vassy; Péter Csermely; Daniel V Veres
Journal:  NPJ Syst Biol Appl       Date:  2022-06-09

2.  The effect of melatonin on the mouse ameloblast-lineage cell line ALCs.

Authors:  Jing Pan; Qianhui Ren; Zhao Yang; Ying Guo; Kubin Kwon; Checheng Shen; Yueying Wang; Fang Ji
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

3.  Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity.

Authors:  Daniela Melnik; Jayashree Sahana; Thomas J Corydon; Sascha Kopp; Mohamed Zakaria Nassef; Markus Wehland; Manfred Infanger; Daniela Grimm; Marcus Krüger
Journal:  Cells       Date:  2020-02-05       Impact factor: 6.600

4.  E2 -mediated EMT by activation of β-catenin/Snail signalling during the development of ovarian endometriosis.

Authors:  Wenqian Xiong; Ling Zhang; Hengwei Liu; Na Li; Yu Du; Haitang He; Zhibing Zhang; Yi Liu
Journal:  J Cell Mol Med       Date:  2019-09-27       Impact factor: 5.310

5.  Bipolar Disorder Treatments and Ovarian Cancer: A Systematic Review.

Authors:  Mario Miniati; Ciro Conversano; Laura Palagini; Beatrice Buccianelli; Mariagrazia Fabrini; Maricia Mancino; Concetta Laliscia; Donatella Marazziti; Fabiola Paiar; Angelo Gemignani
Journal:  Clin Neuropsychiatry       Date:  2020-10

6.  Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition.

Authors:  Chen Chen; Shuang Huang; Chang-Liang Chen; Sing-Bing Su; Dong-Dong Fang
Journal:  Molecules       Date:  2019-10-16       Impact factor: 4.411

Review 7.  The role of glycogen synthase kinase 3 (GSK3) in cancer with emphasis on ovarian cancer development and progression: A comprehensive review.

Authors:  Mislav Glibo; Alan Serman; Valentina Karin-Kujundzic; Ivanka Bekavac Vlatkovic; Berivoj Miskovic; Semir Vranic; Ljiljana Serman
Journal:  Bosn J Basic Med Sci       Date:  2021-02-01       Impact factor: 3.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.